IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $83,000 | -91.7% | 6,600 | -91.3% | 0.01% | -93.4% |
| Q4 2016 | $1,006,000 | -41.2% | 75,960 | +5.1% | 0.12% | -32.2% |
| Q3 2016 | $1,712,000 | +1823.6% | 72,256 | +2243.7% | 0.18% | +1400.0% |
| Q2 2016 | $89,000 | +178.1% | 3,083 | +208.3% | 0.01% | +200.0% |
| Q1 2016 | $32,000 | -68.9% | 1,000 | -58.3% | 0.00% | -75.0% |
| Q4 2015 | $103,000 | +267.9% | 2,400 | +200.0% | 0.02% | +300.0% |
| Q3 2015 | $28,000 | -53.3% | 800 | -38.5% | 0.00% | -50.0% |
| Q2 2015 | $60,000 | +42.9% | 1,300 | -7.1% | 0.01% | +33.3% |
| Q2 2014 | $42,000 | -54.8% | 1,400 | -62.0% | 0.01% | -60.0% |
| Q4 2013 | $93,000 | -69.9% | 3,684 | -81.6% | 0.02% | -74.1% |
| Q1 2013 | $309,000 | – | 20,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |